TY - JOUR
T1 - Defect of regulatory T cells in patients with Omenn syndrome
AU - Cassani, Barbara
AU - Poliani, Pietro Luigi
AU - Moratto, Daniele
AU - Sobacchi, Cristina
AU - Marrella, Veronica
AU - Imperatori, Laura
AU - Vairo, Donatella
AU - Plebani, Alessandro
AU - Giliani, Silvia
AU - Vezzoni, Paolo
AU - Facchetti, Fabio
AU - Porta, Fulvio
AU - Notarangelo, Luigi D.
AU - Villa, Anna
AU - Badolato, Raffaele
PY - 2010/1
Y1 - 2010/1
N2 - Background: Omenn syndrome (OS) is an autosomal-recessive disorder characterized by severe immunodeficiency and T-cell-mediated autoimmunity. The disease is caused by hypomorphic mutations in recombination-activating genes that hamper the process of Variable (V) Diversity (D) Joining (J) recombination, leading to the generation of autoreactive T cells. We have previously shown that in OS the expression of autoimmune regulator, a key factor governing central tolerance, is markedly reduced. Objective: Here, we have addressed the role of peripheral tolerance in the disease pathogenesis. Methods: We have analyzed forkhead box protein P3 (FOXP3) expression in peripheral blood T cells of 4 patients with OS and in lymphoid organs of 8 patients with OS and have tested the suppressive activity of sorted CD4+ CD25high peripheral blood T cells in 2 of these patients. Results: We have observed that CD4+CD25highT cells isolated ex vivo from patients with OS failed to suppress proliferation of autologous or allogenic CD4+ responder T cells. Moreover, despite individual variability in the fraction of circulating FOXP3+ CD4 cells in patients with OS, the immunohistochemical analysis of FOXP3 expression in lymph nodes and thymus of patients with OS demonstrated a severe reduction of this cell subset compared with control tissues. Conclusion: Overall, these results suggest a defect of regulatory T cells in OS leading to a breakdown of peripheral tolerance, which may actively concur to the development of autoimmune manifestations in the disease.
AB - Background: Omenn syndrome (OS) is an autosomal-recessive disorder characterized by severe immunodeficiency and T-cell-mediated autoimmunity. The disease is caused by hypomorphic mutations in recombination-activating genes that hamper the process of Variable (V) Diversity (D) Joining (J) recombination, leading to the generation of autoreactive T cells. We have previously shown that in OS the expression of autoimmune regulator, a key factor governing central tolerance, is markedly reduced. Objective: Here, we have addressed the role of peripheral tolerance in the disease pathogenesis. Methods: We have analyzed forkhead box protein P3 (FOXP3) expression in peripheral blood T cells of 4 patients with OS and in lymphoid organs of 8 patients with OS and have tested the suppressive activity of sorted CD4+ CD25high peripheral blood T cells in 2 of these patients. Results: We have observed that CD4+CD25highT cells isolated ex vivo from patients with OS failed to suppress proliferation of autologous or allogenic CD4+ responder T cells. Moreover, despite individual variability in the fraction of circulating FOXP3+ CD4 cells in patients with OS, the immunohistochemical analysis of FOXP3 expression in lymph nodes and thymus of patients with OS demonstrated a severe reduction of this cell subset compared with control tissues. Conclusion: Overall, these results suggest a defect of regulatory T cells in OS leading to a breakdown of peripheral tolerance, which may actively concur to the development of autoimmune manifestations in the disease.
KW - anergy and tolerance
KW - FOXP3
KW - Immunodeficiency
KW - Omenn syndrome
KW - regulatory T cells
KW - thymus and the development of T lymphocytes
KW - V(D)J recombination
UR - http://www.scopus.com/inward/record.url?scp=73149109976&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=73149109976&partnerID=8YFLogxK
U2 - 10.1016/j.jaci.2009.10.023
DO - 10.1016/j.jaci.2009.10.023
M3 - Article
C2 - 20109747
AN - SCOPUS:73149109976
SN - 0091-6749
VL - 125
SP - 209
EP - 216
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
IS - 1-3
ER -